ClinicalTrials.Veeva

Menu

Ultrasound Guided Median Nerve Hydrodissection Using Dextrose

I

Iraqi Board of medical specialties

Status

Completed

Conditions

Carpal Tunnel Syndrome

Treatments

Procedure: dextrose 5% median nerve hydrodissection

Study type

Interventional

Funder types

Other

Identifiers

NCT05725460
iraqiboard

Details and patient eligibility

About

to compare the efficacy of dextrose 5% with steroid hydrodissection in patients with carpal tunnel syndrome

Full description

in some cases there is prohibition to use steroid with example the patient rejection to use steroid the maneuver planned median nerve hydrodissection using ultrasound and 10 mld of dextrose 5%, unleash the median nerve for the surrounding structure and short follow up planned to be 2 weeks

Enrollment

40 patients

Sex

All

Ages

20 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

severe carpal tunnel syndrome failed medical management -

Exclusion criteria

previous failed surgery previous failed injection previous failed trial of hydrodissection cervical or brachial nerve entrapment wrist osteoarthritis or rheumatoid pregnant diabetes mellitus

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

dextrose 5%
Experimental group
Description:
10 mls of dextrose under ultrasound to separate the median nerve from adjacent structures
Treatment:
Procedure: dextrose 5% median nerve hydrodissection
steroid
Active Comparator group
Description:
10 mls of steroid used to separate the median nerve from adjacent structures
Treatment:
Procedure: dextrose 5% median nerve hydrodissection

Trial contacts and locations

1

Loading...

Central trial contact

mohammed al juboori, attendant

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems